|
⚲
|
| Keyboard |
| Vu Quan Anh
✚
|
|
|---|---|
| CIK # | 0001892297 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001892297] | |
| 4 | [0001892297] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Vu Quan Anh | |
| Monopar Therapeutics | |
| Histogenics Corp | |
| ETHZilla Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Monopar Therapeutics MNPR
Common Stock
|
2025-12-26 | Buy | 1,500 | $69.95 | 104,925 |
|
Monopar Therapeutics MNPR
Stock Options · derivative
|
2025-12-02 | Grant | 7,135 | $0.00 | |
|
Monopar Therapeutics MNPR
Restricted Stock Units · derivative
|
2025-12-02 | Grant | 9,826 | $0.00 | |
|
Monopar Therapeutics MNPR
Stock Options · derivative
|
2025-03-03 | Grant | 25,000 | $0.00 | |
|
ETHZilla Corp ATNF
Common Stock
|
2021-12-16 | Buy | 8,000 | $3.98 | 31,840 |
|
ETHZilla Corp ATNF
Common Stock
|
2021-12-10 | Buy | 4,500 | $3.90 | 17,550 |
|
ETHZilla Corp ATNF
Stock Option (Right to Buy) · derivative
|
2021-12-08 | Grant | 275,000 | $0.00 |